Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | GPTHEALTH FY26 | GKSL FY26 | SHALBY FY26 | INDRAMEDCO FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 26.11× | 68.88× | 37.99× | ◆ 15.66× | 40.84× -36% | |
| P/B | 4.10× | 5.35× | ◆ 1.31× | 3.88× | 3.52× +16% | |
| EV/EBITDA | 12.74× | 48.77× | 12.44× | ◆ 9.78× | 23.66× -46% | |
| Market Cap | ₹1,103 Cr | ₹1,352 Cr | ₹1,319 Cr | ₹2,875 Cr | ₹1,849 Cr -40% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | ◆ 12.35% | 10.50% | 11.43% | |
| Revenue CAGR 5Y | — | — | — | 19.30% | 19.30% | |
| Net Income CAGR 3Y | — | — | -19.97% | ◆ 28.69% | 4.36% | |
| Revenue YoY (latest Q) | ◆ 17.83% | — | 11.74% | 8.35% | 10.04% +78% | |
| Net Income YoY (latest Q) | ◆ 65.73% | — | 36.70% | 8.33% | 22.52% +192% | |
| Profitability | ||||||
| EBITDA Margin | 17.81% | ◆ 32.85% | 12.51% | 18.00% | 21.12% -16% | |
| Net Income Margin | 8.93% | ◆ 20.50% | 3.04% | 12.39% | 11.98% -25% | |
| Return on Common Equity | 16.32% | 6.14% | 3.74% | ◆ 27.47% | 12.45% +31% | |
| Return on Capital Employed | 16.42% | 8.24% | 5.79% | ◆ 29.88% | 14.64% +12% | |
| Return on Assets | 9.95% | 5.65% | 1.96% | ◆ 19.93% | 9.18% +8% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.06× | 0.06× | 0.54× | ◆ 0.00× | 0.20× -70% | |
| Interest Coverage | 6.93× | 11.84× | 1.87× | ◆ 37.09× | 16.93× -59% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹473 Cr | ₹82 Cr | ₹1,141 Cr | ₹1,483 Cr | ₹902 Cr -48% | |
| Net Income | ₹42.2 Cr | ₹16.8 Cr | ₹34.7 Cr | ₹184 Cr | ₹78.4 Cr -46% | |
| Total Assets | ₹465 Cr | ₹298 Cr | ₹1,839 Cr | ₹991 Cr | ₹1,043 Cr -55% | |
| EPS | ₹5.15 | ₹2.49 | ₹3.23 | ₹20.03 | ₹8.58 -40% | |
| Book Value per Share | ₹32.84 | ₹32.03 | ₹93.49 | ₹80.76 | ₹68.76 -52% | |